Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers-Reference-Cited by-同舟云学术

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

Published:2004-06 Issue:5 Volume:15 Page:499-502
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Awada A.,Gil T.,Sales F.,Dubuisson M.,Vereecken P.,Klastersky J.,Moerman C.,de Valeriola D.,Piccart M. J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference12 articles.

1. Temozolomide: a new oral cytotoxic chemotherapy agent with promising activity against primary brain tumours;O'Reilly;Eur J Cancer,1993

2. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

3. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases;Abrey;J Neuro-Oncol,2001

4. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes;Gabizon;Cancer Res,1994

5. Phase II study of liposomal doxorubicin in refractory ovarian cancer: anti-tumor activity and toxicity modification by liposomal encapsulation;Muggia;J Clin Oncol,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of nanoparticle drug delivery system for the treatment of glioma;Frontiers in Bioengineering and Biotechnology;2024-06-11

2. Revisiting Temozolomide's role in solid tumors: Old is gold?;Journal of Cancer;2024

3. Liposome Nanocarriers for Peptide Drug Delivery;Peptide Therapeutics;2022

4. Liposomal nanostructures: Properties and applications;Nanoscale Processing;2021

5. Liposome: classification, preparation, and applications;Nanoscale Research Letters;2013-02-22